Eslit, Jesa Mae .
HRN: 27-44-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
METRONIDAZOLE 500MG (TAB)
07/09/2025
07/16/2025
PO
500mg
TID
Thickly Msaf
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: